HCAT Logo

Health Catalyst, Inc. (HCAT) 

NASDAQ
Market Cap
$419.85M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
239 of 958
Rank in Industry
6 of 43

Largest Insider Buys in Sector

HCAT Stock Price History Chart

HCAT Stock Performance

About Health Catalyst, Inc.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor …

Insider Activity of Health Catalyst, Inc.

Over the last 12 months, insiders at Health Catalyst, Inc. have bought $204,525 and sold $1.33M worth of Health Catalyst, Inc. stock.

On average, over the past 5 years, insiders at Health Catalyst, Inc. have bought $1.94M and sold $32.55M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Burton Daniel D. (Chief Executive Officer) — $204,525.

The last purchase of 26,200 shares for transaction amount of $204,525 was made by Burton Daniel D. (Chief Executive Officer) on 2024‑02‑27.

List of Insider Buy and Sell Transactions, Health Catalyst, Inc.

2024-12-16SaleChief People Officer
6,442
0.0106%
$7.88$50,794-9.68%
2024-12-06SaleChief Financial Officer
19,599
0.0323%
$8.32$163,050-4.31%
2024-12-06SaleGeneral Counsel
19,268
0.0317%
$8.32$160,294-4.31%
2024-12-04SaleChief Operating Officer
22,773
0.0367%
$7.70$175,243+1.01%
2024-12-02SaleChief Commercial Officer
7,500
0.012%
$8.94$67,073-11.42%
2024-11-15SaleChief People Officer
1,365
0.0022%
$8.50$11,603+6.27%
2024-11-05SaleChief Operating Officer
5,209
0.0086%
$7.70$40,127+3.70%
2024-10-15SaleChief People Officer
1,324
0.0021%
$8.16$10,804-3.29%
2024-10-03SaleChief Operating Officer
5,209
0.0079%
$7.68$40,011+6.55%
2024-09-16SaleChief People Officer
1,324
0.0022%
$8.43$11,161-4.46%
2024-09-06SaleChief Financial Officer
2,899
0.0049%
$7.39$21,427+11.66%
2024-09-06SaleGeneral Counsel
2,466
0.0041%
$7.39$18,222+11.66%
2024-09-04SaleChief Operating Officer
8,137
0.0135%
$7.58$61,718+7.89%
2024-09-03SaleChief Commercial Officer
7,500
0.0124%
$7.22$54,174+12.14%
2024-08-15SaleChief People Officer
1,328
0.0023%
$6.57$8,7250.00%
2024-08-05SaleChief Operating Officer
5,209
0.0091%
$6.19$32,224+31.73%
2024-07-15SaleChief People Officer
1,290
0.0023%
$6.51$8,3980.00%
2024-07-03SaleChief Operating Officer
5,208
0.0089%
$6.15$32,0490.00%
2024-06-17SaleChief People Officer
1,290
0.0021%
$6.37$8,221+21.18%
2024-06-12SaleChief Financial Officer
2,823
0.005%
$6.83$19,281+15.72%

Insider Historical Profitability

3.52%
Burton Daniel D.Chief Executive Officer
1172623
1.9271%
$6.90523+4.51%
Gallagher Duncan
35405
0.0582%
$6.9010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$40.39M9.095.36M+0.86%+$345,732.44<0.01
The Vanguard Group$33.71M7.584.48M-18.73%-$7.77M<0.01
Wellington Management Company$19.78M4.452.63M-16.37%-$3.87M<0.01
BNY Mellon$18.74M4.222.49M+104.31%+$9.57M<0.01
Daventry Group Lp$16.29M3.662.16M+12.63%+$1.83M6.51
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.